Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theresa Hahn

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2013
Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patientsPhilip L McCarthy, Theresa Hahn
Blood|February 19, 2011
Self-determinism: alloBMT for AMLPhilip L McCarthy, Theresa Hahn
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
HLA DR15 and immunobiologic outcomesMinoo Battiwalla, Theresa Hahn, Philip L McCarthy
Leukemia Research Reports|June 18, 2014
Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk diseasePamela Paplham, Theresa Hahn, Karen Dubel, et al.
Cancer Research Communications|November 14, 2025
Risk Factors beyond Chemotherapy Exposure for Secondary Myeloid Neoplasms after Hematologic Cancers: A SEER-Based StudyAbhay Singh, Theresa Hahn, Rahul Mishra, et al.
JNCI Cancer Spectrum|September 19, 2025
Therapy-Related-Myeloid-Neoplasm-Risk Score: a convenient score for therapy-related myeloid neoplasms risk assessment in adult cancer patientsAbhay Singh, Megan M Herr, Rahul Mishra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2015
Population-Based Analysis of Hematologic Malignancy Referrals to a Comprehensive Cancer Center, Referrals for Blood and Marrow Transplantation, and Participation in Clinical Trial, Survey, and Biospecimen Research by RaceAlyssa Clay, Brittany Peoples, Yali Zhang, et al.
Leukemia & Lymphoma|September 4, 2008
Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignanciesCharu Aggarwal, Sameer Gupta, Theresa Hahn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 29, 2019
Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantationRandy Albelda, Emily Wiemers, Theresa Hahn, et al.
JAMA Network Open|September 18, 2024
Use of Hematopoietic Cell Transplant for Hematologic Cancers by Race, Ethnicity, and AgeTheresa Hahn, Megan M Herr, Ruta Brazauskas, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Hematology. American Society of Hematology. Education Program|December 10, 2013
Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patientsPhilip L McCarthy, Theresa Hahn
Blood|February 19, 2011
Self-determinism: alloBMT for AMLPhilip L McCarthy, Theresa Hahn
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
HLA DR15 and immunobiologic outcomesMinoo Battiwalla, Theresa Hahn, Philip L McCarthy
Leukemia Research Reports|June 18, 2014
Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk diseasePamela Paplham, Theresa Hahn, Karen Dubel, et al.
Cancer Research Communications|November 14, 2025
Risk Factors beyond Chemotherapy Exposure for Secondary Myeloid Neoplasms after Hematologic Cancers: A SEER-Based StudyAbhay Singh, Theresa Hahn, Rahul Mishra, et al.
JNCI Cancer Spectrum|September 19, 2025
Therapy-Related-Myeloid-Neoplasm-Risk Score: a convenient score for therapy-related myeloid neoplasms risk assessment in adult cancer patientsAbhay Singh, Megan M Herr, Rahul Mishra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2015
Population-Based Analysis of Hematologic Malignancy Referrals to a Comprehensive Cancer Center, Referrals for Blood and Marrow Transplantation, and Participation in Clinical Trial, Survey, and Biospecimen Research by RaceAlyssa Clay, Brittany Peoples, Yali Zhang, et al.
Leukemia & Lymphoma|September 4, 2008
Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignanciesCharu Aggarwal, Sameer Gupta, Theresa Hahn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 29, 2019
Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantationRandy Albelda, Emily Wiemers, Theresa Hahn, et al.
JAMA Network Open|September 18, 2024
Use of Hematopoietic Cell Transplant for Hematologic Cancers by Race, Ethnicity, and AgeTheresa Hahn, Megan M Herr, Ruta Brazauskas, et al.
Pageof 14